Everything below concerns Melanotan II. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2025-09-18. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Research interest has centred on photoprotection and pigmentation, with a smaller body of work on appetite and sexual function. Published human data remain limited to small, frequently uncontrolled studies, and the compound has never received marketing approval from a national medicines regulator. Most laboratory work treats it as a pharmacological tool for probing melanocortin signalling in cell culture or animal models. Whether pigmentation changes observed in people translate into measurable protection against ultraviolet-induced DNA damage remains an open question.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, the naturally occurring peptide involved in pigmentation signalling. Its sequence is conventionally written as Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, with a lactam bridge joining the aspartate side chain to the lysine side chain. The empirical formula is C50H69N15O9 and the monoisotopic mass lies near 1023.5 daltons. N-terminal acetylation and the D-configured phenylalanine both increase resistance to enzymatic breakdown compared with the parent hormone.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic cyclic heptapeptide | Analog of alpha-melanocyte-stimulating hormone |
| Primary receptor family | Melanocortin receptors MC1R through MC5R | Binding is not subtype-selective |
| Development period | 1980s | Synthesized during pigmentation and appetite research |
| Regulatory status | Not an approved medicine | No major regulator has authorized human use |
| Related compound | Afamelanotide | Linear analog studied for photoprotection |
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Receptor-binding studies classify melanotan II as a non-selective melanocortin agonist. It interacts with MC1R, MC3R, MC4R and MC5R, with reported affinities in the low nanomolar range and no strong subtype preference. Activation of MC1R on dermal melanocytes shifts pigment synthesis toward eumelanin, the dark polymer deposited in melanosomes and transferred to keratinocytes. Because the same peptide engages MC4R in the hypothalamus, it also appears in animal work on food intake and erectile response, which is why it is discussed in both pigment and metabolic research. Which receptor populations dominate after systemic exposure in humans is not fully established.
=== Anti-CD47 therapy === Many tumor cells overexpress CD47 to escape immunosurveilance of host immune system. CD47 binds to its receptor signal-regulatory protein alpha (SIRPα) and downregulate phagocytosis of tumor cell. Therefore, anti-CD47 therapy aims to restore clearance of tumor cells. Additionally, growing evidence supports the employment of tumor antigen-specific T cell response in response to anti-CD47 therapy. A number of therapeutics are being developed, including anti-CD47 antibodies, engineered decoy receptors, anti-SIRPα antibodies and bispecific agents. As of 2017, wide range of solid and hematologic malignancies were being clinically tested.
In Taiwan, researchers were able to produce kefir in a laboratory using microorganisms isolated from kefir grains. They report that the resulting kefir drink had chemical properties similar to homemade kefir.
In 1944, it was officially decided to abolish the conventional name "Improved Japanese Breed" and call the breeds Japanese Black, Japanese Brown, and Japanese Polled, as the characteristics of each breed had been clarified as a result of improvements. This officially recognized the three crossbreeds as fixed breeds. Then, in 1957, the Japanese Shorthorn was added. They are collectively known as Wagyu. The Uruguay Round of the General Agreement on Tariffs and Trade (GATT) from 1986 to 1994, which set rules for liberalization of international trade, decided to liberalize imports of foreign beef to Japan. Beef imports have been liberalized since 1991. In 1993, beef imports jumped 34% over the previous year, and as a result, Japan's beef self-sufficiency rate dropped below 50%. The liberalization of beef imports has brought about changes in Japan's domestic Wagyu beef production system. In order to compete with cheaper foreign beef, Japanese livestock farmers have become more focused on raising the Japanese Black breed, which has a unique marbling characteristic. As a result, the number of the other three Wagyu breeds has decreased. Following the outbreak of Bovine Spongiform Encephalopathy (BSE) in Japan, the Law for Special Measures Concerning the Management and Relay of Information for Individual Identification of Cattle (Beef Traceability Law) was enacted in 2003. This law stipulates the attachment of ear tags to cattle, the notification, recording, and storage of historical information from birth to beef, and the publication of recorded information on the Internet.
The thymus continues to grow after birth, reaching the relative maximum size by puberty. It is most active in fetal and neonatal life. It increases to a mass of 20 to 50 grams by puberty. It then begins to decrease in size and activity in a process called thymic involution. After the first year of life the amount of T cells produced begins to fall. Fat and connective tissue fill a part of the thymic volume. During involution, the thymus decreases in size and activity. Fat cells are present at birth, but increase in size and number markedly after puberty, invading the gland from the walls between the lobules first, then into the cortex and medulla. This process continues into old age, where whether with a microscope or with the human eye, the thymus may be difficult to detect, although typically weighs 5–15 grams. Additionally, there is an increasing body of evidence showing that age-related thymic involution is found in most, if not all, vertebrate species with a thymus, suggesting that this is an evolutionary process that has been conserved.[40] The atrophy is due to the increased circulating level of sex hormones, and chemical or physical castration of an adult results in the thymus increasing in size and activity. Severe illness or human immunodeficiency virus infection may also result in involution.
The advantage of diamorphine over morphine is that diamorphine is more fat soluble and therefore more potent by injection, so smaller doses of it are needed for the same effect on pain. Both of these factors are advantageous if giving high doses of opioids via the subcutaneous route, which is often necessary for palliative care. It is also used in the palliative management of bone fractures and other trauma, especially in children. In the trauma context, it is primarily given by nose in hospital; although a prepared nasal spray is available, it has traditionally been made by the attending physician, generally from the same "dry" ampoules as used for injection. In children, Ayendi nasal spray is available at 720 micrograms and 1600 micrograms per 50 microlitres actuation of the spray, which may be preferable as a non-invasive alternative in pediatric care, avoiding the fear of injection in children.
Sources: en.wikipedia.org
=== X-ray photoelectron spectroscopy (XPS) === XPS is utilized to analyze the chemical composition of the surface. X-rays are used to irradiate the sample and measure the energies of the emitted photoelectrons. XPS assesses the surface chemistry and can detect any chemical changes induced by ion milling. This process can tell how much damage ion milling has caused to the surface after ion bombardment.
== Deterministic versus stochastic epidemic models == The deterministic models presented here are valid only in case of sufficiently large populations, and as such should be used cautiously. These models are only valid in the thermodynamic limit, where the population is effectively infinite. In stochastic models, the long-time endemic equilibrium derived above, does not hold, as there is a finite probability that the number of infected individuals drops below one in a system. In a true system then, the pathogen may not propagate, as no host will be infected. But, in deterministic mean-field models, the number of infected can take on real, namely, non-integer values of infected hosts, and the number of hosts in the model can be less than one, but more than zero, thereby allowing the pathogen in the model to propagate. The reliability of compartmental models is limited to compartmental applications. One of the possible extensions of mean-field models considers the spreading of epidemics on a network based on percolation theory concepts. Stochastic epidemic models have been studied on different networks and more recently applied to the COVID-19 pandemic.
In the north, a scrub-covered, semi-desert plain referred as the Guban lies parallel to the Gulf of Aden littoral. With a width of twelve kilometres in the west to as little as two kilometres in the east, the plain is bisected by watercourses that are essentially beds of dry sand except during the rainy seasons. When the rains arrive, the Guban's low bushes and grass clumps transform into lush vegetation. This coastal strip is part of the Ethiopian xeric grasslands and shrublands ecoregion. Cal Madow is a mountain range in the northeastern part of the country. Extending from several kilometres west of the city of Bosaso to the northwest of Erigavo, it features Somalia's highest peak, Shimbiris, which sits at an elevation of about 2,416 metres (7,927 ft). The rugged east–west ranges of the Karkaar Mountains also lie to the interior of the Gulf of Aden littoral. In the central regions, the country's northern mountain ranges give way to shallow plateaus and typically dry watercourses that are referred to locally as the Ogo. The Ogo's western plateau, in turn, gradually merges into the Haud, an important grazing area for livestock. Somalia has only two permanent rivers, the Jubba and Shabele, both of which begin in the Ethiopian Highlands. These rivers flow southwards, with the Jubba River entering the Indian Ocean at Kismayo. The Shabele River used to enter the sea near Merca, but now reaches a point just southwest of Mogadishu. After that, it consists of swamps and dry reaches before finally disappearing in the desert terrain east of Jilib, near the Jubba River.
== Further reading == Jung, Hans Joachim (2000). Panzer Soldiers for "God, Honor and Fatherland": The History of Panzerregiment Grossdeutschland. Winnipeg, Canada: J. J. Fedorowicz. ISBN 0-921991-51-7. Herbst, Jurgen (2002). Requiem for a German Past: A Boyhood among the Nazis. Madison, Wisconsin: University of Wisconsin Press. ISBN 978-0-299-16414-0. de Lannoy, François; Perrigault, Jean-Claude (1998). La Grossdeutschland: du régiment au Panzerkorps, 1939–1945 [Grossdeutschland: From Regiment to Panzer Corps 1939–1945] (in French). Bayeux, France: Heimdal. ISBN 2-84048-110-3. Lucas, James (1978). Germany's Elite Panzer Force: Grossdeutschland. London: Macdonald and Jane's. ISBN 0-35401-165-0. McGuirl, Thomas; Spezzano, Remy (1997). God, Honor, Fatherland: A Photo History of Panzergrenadier Division Grossdeutschland on the Eastern Front 1942 - 1944. Connecticut: Southbury. ISBN 0-9657584-0-0. Novotny, Alfred (2002). The Good Soldier: From Austrian Social Democracy to Communist Captivity with a Soldier of Panzer-Grenadier Division Grossdeutschland. Bedford, Pennsylvania: Aberjona Press. ISBN 0-966638-99-9. Quarrie, Bruce (1977). Panzer-Grenadier Division Grossdeutschland. London: Osprey Publishing Group. ISBN 0-85045-055-1.
Sources: en.wikipedia.org
No regulator in a major market has approved it for human use. It appears in research settings and in products marketed outside pharmacy channels. Legal status for personal possession varies by country.
Afamelanotide is a linear analog that has received approval in some jurisdictions for a specific photoprotection indication. Melanotan II is cyclic and less selective across melanocortin receptors. The two are related but are not interchangeable in regulatory or clinical terms.
A compound that activates several receptor subtypes may produce effects beyond pigmentation. Selectivity influences which tissues respond and shapes the side-effect profile described in reports. Designing subtype-selective analogs is a stated goal of melanocortin research.
It is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, containing seven amino acids with a lactam ring and a D-configured phenylalanine residue. It is supplied as a lyophilised powder for laboratory research.